D.A. Davidson & Co’s Bioverativ Inc. Common Stock BIVV Stock Holding History

D.A. Davidson & Co’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,210	Closed	-$497K	–	1177
2017 Q4	$497K	Buy	9,210 +51	+0.6%	+$2.79K	0.01%	659
2017 Q3	$522K	Sell	9,159 -108	-1%	-$6.33K	0.01%	664
2017 Q2	$557K	Sell	9,267 -129	-1%	-$7.35K	0.01%	594
2017 Q1	$511K	Buy	+9,396	New	+$463K	0.01%	602

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

D.A. Davidson & Co's BIVV Position: Q1 2018 in Review

D.A. Davidson & Co sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 9,210 shares — an estimated $497K sold.

D.A. Davidson & Co first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $557K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

D.A. Davidson & Co reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
D.A. Davidson & Co sold 9,210 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $497K.
D.A. Davidson & Co first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
D.A. Davidson & Co's Bioverativ Inc. Common Stock position peaked at $557K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on D.A. Davidson & Co's 13F filing for Q1 2018, filed 4 May 2018.